We just received data on a new analyst forecast for $CRCL. James Faucette from Morgan Stanley set a price target of 66.0 for CRCL.
To track analyst ratings and price targets for $CRCL, check out Quiver Quantitative's $CRCL forecast page.
Should you buy $CRCL?
Some analysts are better than others. To view the past performance of Morgan Stanley, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CRCL Price Targets
Multiple analysts have issued price targets for $CRCL recently. We have seen 13 analysts offer price targets for $CRCL in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- James Faucette from Morgan Stanley set a target price of $66.0 on 02/02/2026
- Dan Dolev from Mizuho set a target price of $77.0 on 01/28/2026
- James Yaro from Goldman Sachs set a target price of $88.0 on 01/06/2026
- Mike Colonnese from HC Wainwright & Co. set a target price of $85.0 on 12/19/2025
- Daniel Krebs from Wolfe Research set a target price of $60.0 on 12/02/2025
- David Koning from Baird set a target price of $110.0 on 11/14/2025
- Kenneth Worthington from JP Morgan set a target price of $100.0 on 11/13/2025
$CRCL Insider Trading Activity
$CRCL insiders have traded $CRCL stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $CRCL stock by insiders over the last 6 months:
- JEREMY ALLAIRE (Chairman and CEO) has made 0 purchases and 11 sales selling 373,438 shares for an estimated $46,876,237.
- RAJEEV V DATE has made 0 purchases and 15 sales selling 530,446 shares for an estimated $44,606,677.
- PATRICK SEAN NEVILLE has made 0 purchases and 4 sales selling 328,943 shares for an estimated $39,092,069.
- NIKHIL CHANDHOK (Chief Product & Tech. Officer) has made 0 purchases and 7 sales selling 170,000 shares for an estimated $15,861,753.
- JEREMY FOX-GEEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 73,830 shares for an estimated $8,309,405.
- HEATH TARBERT (President) has made 0 purchases and 3 sales selling 36,273 shares for an estimated $4,448,380.
- M MICHELE BURNS sold 29,946 shares for an estimated $3,805,387
- TAMARA L SCHULZ (Chief Accounting Officer) has made 0 purchases and 3 sales selling 6,274 shares for an estimated $562,327.
- DANITA K OSTLING has made 0 purchases and 2 sales selling 3,952 shares for an estimated $389,371.
- CRAIG W. BRODERICK sold 1,035 shares for an estimated $131,522
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRCL Revenue
$CRCL had revenues of $739.8M in Q3 2025. This is an increase of 65.95% from the same period in the prior year.
You can track CRCL financials on Quiver Quantitative's CRCL stock page.
$CRCL Hedge Fund Activity
We have seen 266 institutional investors add shares of $CRCL stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 2,458,044 shares (+356.2%) to their portfolio in Q3 2025, for an estimated $325,887,473
- ATLAS MERCHANT CAPITAL LLC added 1,687,376 shares (+inf%) to their portfolio in Q3 2025, for an estimated $223,712,310
- SUMITOMO MITSUI TRUST GROUP, INC. added 1,276,310 shares (+98.2%) to their portfolio in Q4 2025, for an estimated $101,211,383
- GENERAL CATALYST GROUP MANAGEMENT, LLC removed 1,119,728 shares (-5.6%) from their portfolio in Q3 2025, for an estimated $148,453,538
- BLACKROCK, INC. added 1,082,068 shares (+31.5%) to their portfolio in Q3 2025, for an estimated $143,460,575
- FMR LLC removed 787,509 shares (-5.7%) from their portfolio in Q3 2025, for an estimated $104,407,943
- YONG RONG (HK) ASSET MANAGEMENT LTD added 752,700 shares (+311.7%) to their portfolio in Q4 2025, for an estimated $59,689,110
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
